Bitterman Robert Jinsider trades

In SEC Form 4 filings, Bitterman Robert J is listed as Chairman, Pres. & CEO of Phio Pharmaceuticals Corp. (PHIO). In the last 90 days, Bitterman Robert J bought $2.1K of Phio Pharmaceuticals Corp. (PHIO) on the open market and sold none. The purchase was $2.1K of Phio Pharmaceuticals Corp. (PHIO) on Sep 22. Took part in a cluster buy; the latest at Phio Pharmaceuticals Corp. (PHIO), where 3 insiders bought within 8 days, ending Sep 29.

Companies and roles

Company	Role	Transactions	Last filed
PHIOPhio Pharmaceuticals Corp.	Chairman, Pres. & CEO	3	Sep 29

Cluster buys

PHIO: 3 insiders bought $19K between Sep 22 – Sep 29.

Form 4 historysince 2026-09-15

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
PHIOPhio Pharmaceuticals Corp.	Sep 28	Sep 29	A	400,000	$0.00	$0	764,871	No	Form 4
PHIOPhio Pharmaceuticals Corp.	Sep 22	Sep 23	P	2,000	$1.03	Purchase +$2,058	364,871	No	Form 4
PHIOPhio Pharmaceuticals Corp.	Sep 11	Sep 15	F	68,550	$1.03	$70,607	362,871	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.